Sía eftir: Last updated date SelectEftirFyrirFrom - To Date Lokadagsetning This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Niðurstöður (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022 10 júní 2022NewsHumanCOVID-19PharmacovigilanceReferrals EMA recommends withdrawal of marketing authorisation for amfepramone medicines 10 júní 2022NewsHumanMedicines EMA publishes annual report 2021 10 júní 2022NewsHumanVeterinaryCorporate EMA adopts first list of critical medicines for COVID-19 8 júní 2022NewsHumanCOVID-19 EMA business hours over Whit Monday holiday, 6 June 2 júní 2022NewsCorporateCOVID-19 EMA appoints Chief Medical Officer 1 júní 2022NewsCorporateGovernance EMA business hours over Ascension Day holidays, 26 and 27 May 24 maí 2022NewsCorporateCOVID-19 EMA guidance supports development of new antibiotics 24 maí 2022NewsHumanRegulatory and procedural guidancePaediatrics Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022 20 maí 2022NewsHumanCOVID-19Medicines First therapy to treat rare genetic nervous system disorder AADC deficiency 20 maí 2022NewsHumanMedicines 1 … 44 45 46 47 48 Page 48 of 383 49 50 51 52 … 383
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2022 10 júní 2022NewsHumanCOVID-19PharmacovigilanceReferrals
EMA recommends withdrawal of marketing authorisation for amfepramone medicines 10 júní 2022NewsHumanMedicines
EMA guidance supports development of new antibiotics 24 maí 2022NewsHumanRegulatory and procedural guidancePaediatrics
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022 20 maí 2022NewsHumanCOVID-19Medicines
First therapy to treat rare genetic nervous system disorder AADC deficiency 20 maí 2022NewsHumanMedicines